Cargando…
Acute kidney injury and COVID-19
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a recent pandemic infectious disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2). COVID-19 may lead to acute kidney injury (AKI). MAIN TEXT: SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4(D...
Autores principales: | Al-kuraishy, Hayder M., Al-Gareeb, Ali I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492093/ https://www.ncbi.nlm.nih.gov/pubmed/34629845 http://dx.doi.org/10.1186/s43162-021-00064-x |
Ejemplares similares
-
Synergistic effect of berberine and pentoxifylline in attenuation of acute kidney injury
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2019) -
Vinpocetine Improves Oxidative Stress and Pro-Inflammatory Mediators in Acute Kidney Injury
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2019) -
Trimetazidine and COVID-19-induced acute cardiac injury: a missed key
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
New insight into the effect of lycopene on the oxidative stress in acute kidney injury
por: Rasheed, Huda A., et al.
Publicado: (2020) -
Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2017)